Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)". Issue 12 (5th September 2022)

Record Type:: Journal Article
Title:: Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)". Issue 12 (5th September 2022)
Main Title:: Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)"
Authors:: Cattrini, Carlo
Messina, Carlo
Mennitto, Alessia
Di Maio, Massimo
Gennari, Alessandra
Olmos, David
Abstract:
Is Part Of:: International journal of cancer. Volume 151:Issue 12(2022)
Journal:: International journal of cancer
Issue:: Volume 151:Issue 12(2022)
Issue Display:: Volume 151, Issue 12 (2022)
Year:: 2022
Volume:: 151
Issue:: 12
Issue Sort Value:: 2022-0151-0012-0000
Page Start:: 2291
Page End:: 2292
Publication Date:: 2022-09-05
Subjects:: Cancer -- Periodicals
Cancer -- Prevention -- Periodicals
616.994
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/ijc.34246 ↗
Languages:: English
ISSNs:: 0020-7136
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4542.156000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24139.xml